Gniadecki R
Department of Dermatological Research, Leo Pharmaceutical Products, Ballerup, Denmark.
J Endocrinol. 1994 Dec;143(3):521-5. doi: 10.1677/joe.0.1430521.
The cellular signalling pathways of a potent 20-epi-22-oxa vitamin D3 analogue (KH 1060) were examined in vivo in a hairless mouse model. Seventy two hours after a single topical application of KH 1060 a thickening of the epidermis (from 24.8 +/- 1.2 microns at 0.01 pmol/cm2 KH 1060 to 124.2 +/- 6 microns at 5 pmol/cm2 KH 1060, P < 0.001) was elicited due to epidermal hyperproliferation. This effect could be blocked by topical 2.5 mumol/cm2 sphingosine, an inhibitor of protein kinase C. Two hours after topical application of 2.5 pmol/cm2 KH 1060 a translocation of protein kinase C activity from cytoplasm to the membrane fractions was observed. Moreover, using a reverse-transcription polymerase chain reaction technique, a transient upregulation of c-fos gene expression was seen 2 hours after topical treatment with KH 1060. The expression of c-fos was dependent on protein kinase C activation, since after pretreatment with the protein kinase C blocker sphingosine, c-fos messenger RNA was not detected. These findings strongly suggest that KH 1060 stimulates epidermal growth through activation of the protein kinase C-c-fos signalling axis in vivo.
在无毛小鼠模型中对一种强效的20-表-22-氧杂维生素D3类似物(KH 1060)的细胞信号通路进行了体内研究。单次局部应用KH 1060 72小时后,由于表皮过度增殖,表皮出现增厚(从0.01 pmol/cm² KH 1060时的24.8±1.2微米增厚至5 pmol/cm² KH 1060时的124.2±6微米,P<0.001)。这种效应可被局部应用的2.5 μmol/cm²鞘氨醇(一种蛋白激酶C抑制剂)阻断。局部应用2.5 pmol/cm² KH 1060两小时后,观察到蛋白激酶C活性从细胞质向膜部分的转位。此外,使用逆转录聚合酶链反应技术,在用KH 1060局部治疗两小时后,可见c-fos基因表达短暂上调。c-fos的表达依赖于蛋白激酶C的激活,因为在用蛋白激酶C阻滞剂鞘氨醇预处理后,未检测到c-fos信使RNA。这些发现强烈表明,KH 1060在体内通过激活蛋白激酶C-c-fos信号轴刺激表皮生长。